ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

BIOG Biotech Growth Trust (the) Plc

950.00
25.00 (2.70%)
Last Updated: 15:56:30
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Biotech Growth Trust (the) Plc LSE:BIOG London Ordinary Share GB0000385517 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  25.00 2.70% 950.00 941.00 950.00 950.00 933.00 942.00 29,818 15:56:30
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Unit Inv Tr, Closed-end Mgmt -32.42M -41.3M -1.0034 -9.40 388.13M

Biotech Grw Tst PLC Issue of Equity

24/11/2020 5:52pm

UK Regulatory


 
TIDMBIOG 
 
THE BIOTECH GROWTH TRUST PLC 
 
                               24 November 2020 
 
Allotment of Ordinary Shares 
 
THE BIOTECH GROWTH TRUST PLC (the "Company") announces the allotment of 25,000 
Ordinary shares of 25p each fully paid from its block listing authority. 
 
These shares were issued today at a price of 1472.00 pence per Ordinary share, 
which equates to a premium to the estimated  cum income net asset value per 
Ordinary share at the time of transaction of 1.1%  The cum income net asset 
value per Ordinary share at the close of business on 23 November 2020 was 
1458.98 pence. 
 
Following this issue, the Company has the ability to issue a further 4,845,634 
Ordinary shares its block listing facility. 
 
Following this transaction the Company hereby notifies the market that it has 
in issue 40,419,769 Ordinary shares of 25p each all with voting rights.  No 
shares were held in treasury at the date of announcement. 
 
The figure of 40,419,769 may be used by shareholders as the denominator for the 
calculation by which they may determine if they are required to notify their 
interest in, or change to their interest in, the Company under the FCA's 
Disclosure Guidance and Transparency Rules. 
 
Enquiries: 
 
Mark Pope 
 
Frostrow Capital LLP 
 
Tel: 020 3 008 4913 
 
 
 
END 
 

(END) Dow Jones Newswires

November 24, 2020 12:52 ET (17:52 GMT)

1 Year Biotech Growth Chart

1 Year Biotech Growth Chart

1 Month Biotech Growth Chart

1 Month Biotech Growth Chart

Your Recent History

Delayed Upgrade Clock